Taking the fuss out of pus.


Whilst many devices are invented, and then search for an application, this novel medical device was created specifically to address a known clinical need. We employed the ‘Biodesign’ design thinking approach that has generate success at Stanford for many years. Since inception, the we have engaged with the WA biodesign, medtech and innovation communities, and their networks span major universities, hospitals, and government research organisations. The team have worked with the UWA Business School’s Master of Biotechnology programme to refine aspects of the business plan, have conducted proof of concept testing at the Clinical Training and Evaluation Centre (CTEC), and were accepted into the national CSIRO ONPrime! pre-accelerator course to develop their understanding of their customer needs utilising the Lean Canvas model. The device is protected by a provisional patent, and strategic world-wide protection will be pursued. Each stage of the project has been undertaken to further ‘de-risk’ the project, and prepare for investment, regulatory approval, and commercialisation.


This sterile, single use device offers a complete solution for out-of-theatre management of abscesses; the device comprises skin penetration, drainage, and collection management components in a convenient package.


Abcease is designed to:

  • Easily reach abscesses, and mitigate the risk of damage to underlying structures by translating rotational force into axial movement

  • Provide access to deep, subcutaneous abscesses, minimising the need for in-theatre treatment with general anaesthesia

  • Integrate entry, drainage, and exudate collection components to streamline treatment and aftercare

  • Move treatment from a high-cost environment (theatre) with associated 2-3 day inpatient stay and general anaesthesia to a lower-cost environment with ambulatory care and local anaesthesia